JOURNAL OF MOLECULAR ENDOCRINOLOGY, published by BIOSCIENTIFICA LTD, is a prestigious academic journal that has made significant contributions to the fields of endocrinology and molecular biology since its inception in 1988. With an impressive impact factor that places it in the Q1 category for Endocrinology and Q2 for Molecular Biology, this journal is recognized for its rigorous peer-reviewed research that addresses key questions at the intersection of molecular mechanisms and hormonal regulation. The journal's accessibility within the Scopus rankings, notably positioned 45th out of 128 in Endocrinology, highlights its relevance and influence in shaping contemporary scientific discourse. Although the journal does not currently offer open access options, it remains an essential resource for researchers, professionals, and students eager to explore groundbreaking discoveries and advancements in the hormonal sciences. The JOURNAL OF MOLECULAR ENDOCRINOLOGY continues to pave the way for critical exploration and innovation, ensuring its place as a vital publication for the advancement of knowledge in molecular endocrinology.

Pituitary is a prominent academic journal dedicated to advancing the understanding of pituitary gland functions, disorders, and treatments within the sphere of Endocrinology, Diabetes, and Metabolism. Published by Springer in the Netherlands, this journal has established itself as a crucial resource for researchers and clinicians alike, as evidenced by its 2023 Category Quartiles ranking in Q2 and Q1, and a commendable Scopus ranking in both Medicine and Biochemistry. With a focus on innovative research and clinical advances, Pituitary covers a wide range of topics including hormone regulation, pituitary tumors, and endocrine therapies. While it does not currently offer Open Access options, the journal's rigorous peer-review process ensures that each article published contributes significantly to the scientific community's knowledge base. Researchers, professionals, and students will find Pituitary an invaluable resource for both current insights and ongoing developments in endocrine health.

Physiology and Pharmacology is a distinguished open access journal that has been disseminating high-quality research in the fields of physiology and pharmacology since its inception in 1997. Published by the Iranian Society of Physiology & Pharmacology, this journal offers a platform for scholars and practitioners to share innovative findings and advancements that contribute to the understanding of biological systems and drug action. With its ISSN 2476-5236 and E-ISSN 2476-5244, it ensures global reach and accessibility. The journal is positioned in the third quartile for Linguistics and Language and fourth quartile in both Pharmacology and Physiology categories according to Scopus rankings, reflecting a commitment to expanding knowledge within these interdisciplinary domains. Set within the academic landscape of Iran, the journal aims to bridge regional research with the international community, providing valuable insights into physiological processes and pharmacological developments. In light of its open access model, the Physiology and Pharmacology journal plays a crucial role in enhancing the visibility of research outcomes and fostering collaboration among researchers, professionals, and students on a global scale.

Frontiers in Endocrinology, published by FRONTIERS MEDIA SA, is a leading open-access journal dedicated to the advancement of research in the fields of endocrinology, diabetes, and metabolism. Established in 2010, this journal has consistently demonstrated its academic excellence, achieving a prominent Q1 quartile ranking in its category as of 2023, and a commendable Scopus rank of #96 out of 244, placing it within the 60th percentile. The journal is committed to disseminating high-quality research that encompasses a wide range of topics within endocrinology, catering to the needs of a diverse audience that includes researchers, medical professionals, and students alike. With the critical goal of fostering knowledge-sharing and collaboration within the scientific community, Frontiers in Endocrinology is an invaluable resource for anyone looking to stay updated on the latest advancements and insights in endocrinology. It operates under a robust open-access model, ensuring that groundbreaking research is accessible to all, thereby driving innovation and progress in this essential field.

JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION, published by TAYLOR & FRANCIS LTD, is a premier academic journal dedicated to advancing our understanding of receptor biology and signal transduction mechanisms. With an ISSN of 1079-9893 and an E-ISSN of 1532-4281, this journal has maintained a reputable standing since its inception in 1980, continually addressing pivotal topics in biochemistry, cell biology, and molecular biology. As evidenced by its 2023 Scopus rankings, which place it in the 64th percentile for Biochemistry and Genetics and Molecular Biology, JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION remains a vital source for cutting-edge research, providing insights that are essential for both academic and practical applications. Although the journal currently offers limited open access options, it stands out in the Q2 and Q3 quartiles of its respective categories, making it an invaluable resource for researchers, professionals, and students aiming to stay abreast of the latest findings and methodologies in receptor and signaling research. The journal's commitment to disseminating high-quality research underscores its significance within the scientific community, fostering innovation and collaboration across disciplines.

FASEB JOURNAL, published by Wiley, stands as a leading interdisciplinary platform in the realm of biological sciences, prominently featured in the United States. With an impressive 2023 impact factor placing it in the Q1 category across various fields including Biochemistry, Biotechnology, Genetics, Molecular Biology, and Medicine (miscellaneous), the journal is recognized for its substantial contribution to advancing knowledge and innovation. It serves as a vital resource for researchers, professionals, and students alike, providing high-quality, peer-reviewed articles that explore the molecular and cellular mechanisms underlying health and disease. The FASEB JOURNAL not only emphasizes accessible scientific communication but also fosters collaboration within these dynamic fields, making it an essential publication for anyone engaged in cutting-edge life sciences research. To explore more about the journal's offerings and access its vast repository of scholarly articles, visit their official page.

DOMESTIC ANIMAL ENDOCRINOLOGY, published by Elsevier Science Inc., is a leading academic journal dedicated to advancing the field of endocrinology as it pertains to domestic animals. With an ISSN of 0739-7240 and an E-ISSN of 1879-0054, this journal serves a crucial role in disseminating high-quality research and insights that bridge veterinary science and animal physiology. The journal is recognized for its impactful contributions, boasting an impressive Q1 ranking in Animal Science and Zoology, further solidified by its prominent positioning in related fields such as Veterinary Science and Food Animals. Covering research from 1984 to 2025, DOMESTIC ANIMAL ENDOCRINOLOGY is an essential resource for researchers, professionals, and students seeking to deepen their understanding of hormonal functions and their implications in animal health and production. Despite not being an Open Access publication, it provides vital access options for institutions and individuals, ensuring that groundbreaking studies reach practitioners and scholars alike.

JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY is a distinguished peer-reviewed journal published by Pergamon-Elsevier Science Ltd, committed to advancing the fields of biochemistry, molecular biology, and endocrinology. With an ISSN of 0960-0760 and an E-ISSN of 1879-1220, this journal has garnered a notable reputation, securing a Q2 ranking in numerous categories, including Biochemistry, Cell Biology, and Clinical Biochemistry, as of 2023. Hailing from the United Kingdom, it serves as a critical platform for the dissemination of impactful research from 1990 to 2025 and beyond. Although it does not currently offer open access options, the journal's comprehensive coverage and rigorous peer review process ensure high-quality publications that significantly contribute to the understanding of steroid biochemistry and related fields. Targeting a diverse audience of researchers, professionals, and students, the journal remains an essential resource for those seeking to stay at the forefront of scientific innovation and discovery.

HORMONE AND METABOLIC RESEARCH, published by GEORG THIEME VERLAG KG, stands as a reputable platform in the fields of biochemistry, endocrinology, and metabolism since its establishment in 1969. This peer-reviewed journal provides critical insights and advancements in the intricate relationships between hormones and metabolic processes, catering to researchers, healthcare professionals, and students alike. With an impressive convergence of knowledge spanning over five decades, it maintains a commendable Q3 ranking in multiple categories, including Biochemistry, Clinical Biochemistry, and Endocrinology, highlighting its contribution to cutting-edge scientific discourse. Although not an open-access journal, it offers a plethora of access options for readers and institutions, ensuring that vital research reaches those who need it most. Located in Stuttgart, Germany, the journal is positioned at the forefront of influential research in hormone and metabolic studies, emphasizing its importance for ongoing investigations into health and disease.

GROWTH HORMONE & IGF RESEARCH is a renowned scholarly journal published by Churchill Livingstone, focusing on advancements in the field of endocrinology, particularly relating to growth hormone and insulin-like growth factors. With an ISSN of 1096-6374 and an E-ISSN of 1532-2238, the journal has established its footprint in the academic community since its inception in 1998, aiming to disseminate high-quality research through rigorous peer review up to the year 2024. Currently holding a category quartile ranking of Q3 in both Endocrinology and Endocrinology, Diabetes and Metabolism, the journal is recognized for its contribution to understanding the complexities of hormonal regulation and metabolic processes. Researchers and professionals benefit from the insights shared in this publication, which bridges gaps between advanced research and clinical practice. Open access options enhance the visibility and accessibility of published studies, fostering an inclusive academic environment for all. The journal is based in the United Kingdom, with production managed at its address in Edinburgh. By providing a dedicated platform for innovative research, GROWTH HORMONE & IGF RESEARCH continues to be an essential resource for those engaged in the evolving domains of endocrinology.